Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,958.80
(
1.33%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
92.14
(
3.69%
)
Bitcoin
74,023.25
(
-2.26%
)
News Focus
News Focus
Post# of 821977
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

manibiotech

Send PM Follow Ignore
Followers 34
Posts 11431
Boards Moderated 0
Alias Born 01/12/2016

manibiotech

Re: Roman516 post# 804916

Sunday, 12/28/2025 8:33:17 PM

Sunday, December 28, 2025 8:33:17 PM

Post# of 821977
“cost factors for NWBO to file with the FDA appear to be beyond their control and financial capabilities,”

Incorrect . Provide some documentation that a drug with orphan status designation in US has significantly more financial burden for an application to FDA as opposed to MHRA
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News